Acorah Software Products - Accounts Production 16.5.460 false true 31 December 2023 1 January 2023 false 1 January 2024 31 December 2024 31 December 2024 10132870 S Hospital Mrs S C Hospital. true iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 10132870 2023-12-31 10132870 2024-12-31 10132870 2024-01-01 2024-12-31 10132870 frs-core:CapitalRedemptionReserve 2024-12-31 10132870 frs-core:SharePremium 2024-12-31 10132870 frs-core:ShareCapital 2024-12-31 10132870 frs-core:RetainedEarningsAccumulatedLosses 2024-12-31 10132870 frs-bus:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 10132870 frs-bus:FilletedAccounts 2024-01-01 2024-12-31 10132870 frs-bus:SmallEntities 2024-01-01 2024-12-31 10132870 frs-bus:AuditExempt-NoAccountantsReport 2024-01-01 2024-12-31 10132870 frs-bus:SmallCompaniesRegimeForAccounts 2024-01-01 2024-12-31 10132870 frs-bus:OrdinaryShareClass1 2024-01-01 2024-12-31 10132870 frs-bus:OrdinaryShareClass1 2024-12-31 10132870 frs-bus:OrdinaryShareClass2 2024-01-01 2024-12-31 10132870 frs-bus:OrdinaryShareClass2 2024-12-31 10132870 1 2024-01-01 2024-12-31 10132870 frs-core:UnlistedNon-exchangeTraded 2024-12-31 10132870 frs-core:UnlistedNon-exchangeTraded 2023-12-31 10132870 frs-core:CostValuation frs-core:UnlistedNon-exchangeTraded 2023-12-31 10132870 frs-core:CostValuation frs-core:UnlistedNon-exchangeTraded 2024-12-31 10132870 frs-core:ProvisionsForImpairmentInvestments frs-core:UnlistedNon-exchangeTraded 2023-12-31 10132870 frs-core:ProvisionsForImpairmentInvestments frs-core:UnlistedNon-exchangeTraded 2024-12-31 10132870 frs-bus:Director1 2024-01-01 2024-12-31 10132870 frs-countries:EnglandWales 2024-01-01 2024-12-31 10132870 2022-12-31 10132870 2023-12-31 10132870 2023-01-01 2023-12-31 10132870 frs-core:CapitalRedemptionReserve 2023-12-31 10132870 frs-core:SharePremium 2023-12-31 10132870 frs-core:ShareCapital 2023-12-31 10132870 frs-core:RetainedEarningsAccumulatedLosses 2023-12-31 10132870 frs-bus:OrdinaryShareClass1 2023-01-01 2023-12-31 10132870 frs-bus:OrdinaryShareClass2 2023-01-01 2023-12-31
Registered number: 10132870
Oneragtime Keli Limited
Unaudited Financial Statements
For The Year Ended 31 December 2024
Contents
Page
Balance Sheet 1—2
Notes to the Financial Statements 3—4
Page 1
Balance Sheet
Registered number: 10132870
2024 2023
Notes $ $ $ $
FIXED ASSETS
Investments 4 85,687 85,687
85,687 85,687
CURRENT ASSETS
Debtors 5 25,097 22,562
Cash at bank and in hand 100 100
25,197 22,662
Creditors: Amounts Falling Due Within One Year 6 (2,535 ) -
NET CURRENT ASSETS (LIABILITIES) 22,662 22,662
TOTAL ASSETS LESS CURRENT LIABILITIES 108,349 108,349
NET ASSETS 108,349 108,349
CAPITAL AND RESERVES
Called up share capital 7 554 554
Share premium account 99,500 99,500
Capital redemption reserve 46 46
Profit and Loss Account 8,249 8,249
SHAREHOLDERS' FUNDS 108,349 108,349
Page 1
Page 2
For the year ending 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board
S Hospital
Director
24/09/2025
The notes on pages 3 to 4 form part of these financial statements.
Page 2
Page 3
Notes to the Financial Statements
1. General Information
Oneragtime Keli Limited is a private company, limited by shares, incorporated in England & Wales, registered number 10132870 . The registered office is 2nd Floor, Heathmans House, 19 Heathmans Road, London, SW6 4TJ.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
2.2. Turnover
Turnover is recognised as management fees equal to the professional fees incurred during the year under review.
2.3. Investments
Where possible, equity investments are valued in accordance with IPEVC (International Private Equity & Venture Capital) valuation guidelines, otherwise they are valued at cost less impairments.
3. Average Number of Employees
Average number of employees, including directors, during the year was: 1 (2023: NIL)
1 -
4. Investments
Unlisted
$
Cost
As at 1 January 2024 85,687
As at 31 December 2024 85,687
Provision
As at 1 January 2024 -
As at 31 December 2024 -
Net Book Value
As at 31 December 2024 85,687
As at 1 January 2024 85,687
5. Debtors
2024 2023
$ $
Due within one year
Other debtors 25,097 22,562
6. Creditors: Amounts Falling Due Within One Year
2024 2023
$ $
Other creditors 2,535 -
Page 3
Page 4
7. Share Capital
2024 2023
Allotted, called up and fully paid $ $
454 Ordinary Shares of $ 1.00 each 454 454
100 Ordinary A shares of $ 1.00 each 100 100
554 554
8. Ultimate Controlling Party
The immediate and ultimate parent undertaking of the company is OneRagtime Venture Cloud a company incorporated in France with registered number SIREN 831125364 and trading address 60 Rue de Londres, Paris, 75008, France. The ultimate controlling party is Mrs S C Hospital.
Page 4